Building the future, one company at a time.

We turn bold ideas
into companies that
move the world forward.

Trillion Cells is a venture-building company that turns ideas into products and businesses. We develop technologies and future-focused ventures that meet critical needs or create new experiences. Our flagship is Liatta, where people discover, learn about, and experience the innovations transforming industries.

Meet our focus
OUR FLAGSHIP PLATFORM

Liatta — Get ahead & stay ahead

Liatta’s illustrated companion with one hand raised in a welcoming wave

Liatta is Trillion Cells’ flagship platform. It is a social learning platform that helps people discover, understand, and virtually interact with innovative products, services, and places across industries. Stories, creative media, and personalized experiences make learning about what’s next more engaging.

Explore Liatta
A dividing cell with nuclei labeled Trillion Cells and Liatta, representing the creation of a venture
The problem Liatta addresses

Bridging the
future-readiness gap

Seeing an innovation is not the same as understanding it. Liatta is built around the challenge of turning awareness into knowledge people can use.

01 / ATTENTION

There is plenty to see.

New technologies, products, and ideas compete for attention. A passing headline or short clip can introduce a subject without explaining how it works.

02 / UNDERSTANDING

Understanding takes more.

Technical explanations can feel unfamiliar or disconnected from everyday life. Engaging content needs enough substance to help an idea make sense.

03 / RELEVANCE

The next step is personal.

People need ways to connect what they learn with their work, interests, and choices—to explore what an innovation could mean for them.

LIATTA’S APPROACH

Bring discovery, explanation, and virtual experience together—so people can explore an idea beyond the headline.

Explore how Liatta works
Inside Liatta · Our flagship platform

How you learn
on Liatta.

Liatta brings discovery, connected learning, and virtual experiences into one platform. Explore its three approaches below.

Liatta is in private beta · Waitlist openJoin Liatta’s waitlist ↗
Trillion Cells · Our venture-building approach

How Trillion Cells
builds ventures.

Our approach moves from exploration to a focused product. Each stage asks a different question: Is the need real? Can the idea work? Will people use it?

01 / DISCOVER

Question the familiar.

Explore unmet needs with the people closest to them. Define the problem before committing to a solution.

02 / INVESTIGATE

Test the possibility.

Investigate technical and commercial feasibility. Use prototypes and feedback to expose assumptions early.

03 / BUILD

Give it a focused start.

Choose a first use case, build deliberately, and let evidence guide the next stage of development.

Beyond our current focus

Four programs exploring where we could build next.

Research & venture development
Research & venture development

Future projects
under exploration.

Beyond Liatta, four programs explore questions in diagnostic access, biomanufacturing, remote presence, and mobility. Their proposed products remain distinct from our flagship platform.

01

Carmensa Health

HealthTech / Product concept: Carmensa
Research & development
THE QUESTION

How can patients and clinicians reach the diagnostic tests they need, even when those tests are unavailable nearby?

PRODUCT DIRECTION / CARMENSA

Carmensa is a personal AI agent being developed to find suitable laboratories, obtain confirmed options, and coordinate referrals from request to results. Its initial focus is diagnostic access across Africa and beyond.

RESEARCH CONTEXT

Building on TC’s clinical-intelligence initiative, the current product direction focuses on diagnostic availability, referral feasibility, and the coordination needs of patients, clinicians, and local laboratories.

Discuss this program ↗
02

Create Biomedicines

BioTech / Product concept: Diagnostic protein
Research & development
THE QUESTION

How can Africa build more of the biomedical materials its diagnostic services depend on?

PRODUCT DIRECTION / DIAGNOSTIC PROTEIN

The initial product direction is diagnostic protein production: investigating scalable, cost-conscious ways to develop materials used in diagnostic applications. A specific protein and validated production process remain to be established.

RESEARCH CONTEXT

The wider program explores platform technologies for local biomanufacturing, aiming to strengthen biomedical self-reliance and support locally developed diagnostic solutions.

Discuss this program ↗
03

Golgie

Connectivity / Prototype: Vue Vision
Prototype project
THE QUESTION

What if distance did not prevent you from seeing a place through someone who is there?

PRODUCT DIRECTION / VUE VISION

Vue Vision is a prototype for live, user-directed visits led by local guides. People abroad—including members of the African diaspora—could visit shops, marketplaces, and familiar neighborhoods remotely.

RESEARCH CONTEXT

The connectivity program investigates real-time telepresence, participation, and exchange across distance. The proposed service pairs remote visitors with local guides, with platform revenue from completed paid visits.

Discuss this program ↗
04

Proteus Adventures

Mobility innovation / Prototype: Ellen
Prototype project
THE QUESTION

How can people communicate where they are going before a taxi stops?

PRODUCT DIRECTION / ELLEN

Ellen is a visual vehicle-hailing device prototype that uses signals to communicate travel intentions. It is the first product direction within Proteus Adventures’ broader ambition to help people move through and explore the world.

RESEARCH CONTEXT

Proteus Adventures brings together mobility technology and exploration. Its starting point is everyday roadside communication, with a longer-term interest in technologies and experiences that make exploration more accessible.

Discuss this program ↗

Programs span research and prototyping; public product availability is not implied. Directions evolve as feasibility and demand are investigated.

About Trillion Cells

One company.
Many possibilities.
A deliberate focus.

Founded in 2024 by Proteus Zolia ↗, Trillion Cells is a venture-building company working across learning, health, life sciences, and connection.

Our name is inspired by the trillions of cells that make human achievement possible. We bring that spirit of coordinated effort to a shared ambition: industries reimagined and lives improved through invention.

“Fight Dogma” expresses our willingness to question familiar approaches. Liatta is our current focus, while four research programs investigate new possibilities in health, life sciences, connectivity, and mobility.

Collaboration

Progress starts
with a conversation.

We welcome conversations around a specific research question, product opportunity, or potential application.

RESEARCH

Investigate together.

Researchers and institutions interested in exploring feasibility and applications.

LIATTA

Bring innovation to learning.

Creators and businesses interested in making emerging ideas accessible.

VENTURE DEVELOPMENT

Help shape a first product.

Technical and domain specialists interested in our exploratory programs.

Build with us

Bring a question.
Start a conversation.

For research collaboration, product partnerships, and company enquiries.

MONROVIA, LIBERIA

Room 201, Seven-Square Workspaces
1st Floor, Yarzue Building, Paynesville

+231 773 886 182
info@trillioncells.com ↗